[The beta-blocking drugs in hyperthyroidism. 2. Effects on metabolic and biochemical changes].
D000293:Adolescent; D000328:Adult; D001481:Basal Metabolism / Q000187:drug effects*; D001786:Blood Glucose / Q000032:analysis; D002395:Catecholamines / Q000652:urine*; D002784:Cholesterol / Q000097:blood*; D004231:Diuresis / Q000187:drug effects; D004573:Electrolytes / Q000378:metabolism*; D005260:Female; D005947:Glucose / Q000378:metabolism; D006801:Humans; D006980:Hyperthyroidism / Q000188:drug therapy* / Q000378:metabolism; D008875:Middle Aged; D011433:Propranolol / Q000627:therapeutic use*; D013565:Sympatholytics / Q000627:therapeutic use*; D000637:Transaminases / Q000378:metabolism
D001786:Blood Glucose; D002395:Catecholamines; D004573:Electrolytes; D013565:Sympatholytics; D002784:Cholesterol; D011433:Propranolol; D000637:Transaminases; D005947:Glucose
I farmaci betabloccanti nell'ipertiroidismo. 2. Effetti sulle modificazioni metaboliche e biochemiche.